The DOI matches its Crossref record; 366 of the 371 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines: Drug-induced liver injury
Abstract
Idiosyncratic (unpredictable) drug-induced liver injury is one of the most challenging liver disorders faced by hepatologists, because of the myriad of drugs used in clinical practice, available herbs and dietary supplements with hepatotoxic potential, the ability of the condition to present with a variety of clinical and pathological phenotypes and the current absence of specific biomarkers. This makes the diagnosis of drug-induced liver injury an uncertain process, requiring a high degree of awareness of the condition and the careful exclusion of alternative aetiologies of liver disease. Idiosyncratic hepatotoxicity can be severe, leading to a particularly serious variety of acute liver failure for which no effective therapy has yet been developed. These Clinical Practice Guidelines summarize the available evidence on risk factors, diagnosis, management and risk minimization strategies for drug-induced liver jury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-induced liver injury (DILI) is an uncommon adverse reaction to drugs, and other chemicals, including herbal and dietary supplements (HDS).”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [2]
In the citing paper
“The vast majority of cases of DILI occur at therapeutic doses in a small proportion of individuals exposed to the drug, representing an idiosyncratic reaction, and therefore unpredictable based on the drug's mechanism of action and related to the uniqueness of the individual [1,2].”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [2]
In the citing paper
“In pediatric medicine, DILI is a rare clinical situation. However, it has high morbidity and mortality, and it is one of the most common causes of acute liver failure. Furthermore, its diagnosis is clinically challenging due to its low incidence and phenotypic variability [6,7,8].”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [7]
In the citing paper
“The lack of a reliable diagnostic biomarker and evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“The lack of reliable diagnostic biomarkers and an evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.2,25–27”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“However, drug rechallenge in DILI cases is potentially dangerous2,75 and is associated with risk of death or requirement for liver transplant.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“High TBil and ALP levels in the second month after an acute DILI episode and the biochemical nonresolution-6 model may help predict the risk of chronic injury and delayed recovery [26,72].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“Its potential value in confirming or excluding hepatocellular injury in cases of elevated ALT levels from a suspected extrahepatic origin (e.g., muscle) has been evaluated [26,175].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
Citations
Cites
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Acetaminophen‐induced acute liver failure
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., REISCH, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,913
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Flagged first, then by citations
5 of the 371 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Nicoletti, 2017, Genome-wide association study (GWAS) to identify genetic risk factors that increase susceptibility to antituberculosis drug-induced liver injury (ATDILI) [Abstract], Hepatology, 66, A-25
- Lim, 2008, Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review, Neurol Asia, 13, 15
- US Food & Drug Administration, 2017, Drugs
- Sanjuan-Jimenez, 2017, Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract], Hepatology, 66, 423A
- Fernández-Castañer, 2008, An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event, Rev Esp Enfermedades Dig, 100, 278
Cited by
Sorted by citations
Items 801–900 of 1,278
Apple Cider Vinegar-Induced Hepatotoxicity: A Rare Case Report
Andonie, C. R., AbuGhannam, S. I., & Ruzayqat, S. M. A. (2025) · Oxford Medical Case Reports · doi:10.1093/omcr/omaf097 · Cited by 1
Bhati, A., Mazumder, A., Bansal, P., & Rani, A. (2025) · Drug Delivery Letters · doi:10.2174/0122103031401073250711115623 · Cited by 1
Leão, M. C. C., Fagg, C. W., Simeoni, L. A., Homem-de-Mello, M., Magalhães, P. O., Silveira, D., & Fonseca-Bazzo, Y. M. (2025) · Natural Product Communications · doi:10.1177/1934578x251360959 · Cited by 1
Ling, J., Xv, Y., Lv, S., Hao, X., Chen, W., Li, D., Liu, W., Zou, Z., Zhu, B., & You, S. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s532870 · Cited by 1
Qi, X., & Liu, X. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010605 · Cited by 1
Kamel, E. M., Alsalamah, S. A., Khadrawy, S. M., Ahmed, N. A., Alkhayl, F. F. A., & Lamsabhi, A. M. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156234 · Cited by 1
TCN-RDP: Predicting Drug-Induced Liver Injury from Time-Series Toxicogenomic Data
Zhao, Z., Li, B., Zuo, H., Chen, R., Deng, R., Geng, J., Sun, C., Wei, L., Lang, M., & Su, R. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01678 · Cited by 1
Shibata, M., Uchida, N., Ooka, A., Shizu, R., & Yoshinari, K. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101505 · Cited by 1
Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report
Lisanti, C., Rossa, S. D., Zottarelli, E., Vida, R., Bolzonello, S., Ros, L. D., Zdjelar, A., Cecchin, E., Perin, T., & Puglisi, F. (2025) · Current Oncology · doi:10.3390/curroncol32110606 · Cited by 1
A practical approach to nutrition in people with cirrhosis
Carbonell, M. J., Graydon, M., Mahmood, S., Lewis, H., Dhar, A., Mullish, B. H., & Tyson, L. D. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103201 · Cited by 1
Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis
Meunier, L., Monet, C., Saviano, A., Farrugia, M. A., Villeret, F., Lebossé, F., Khaldi, M., Moranne, O. P., Chambon, C., Ichaı̈, P., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101684 · Cited by 1
Li, Z., Wang, X., Li, D., Sun, Y., Zhang, L., & Li, X. (2025) · Nucleic Acid Therapeutics · doi:10.1177/21593337251391029 · Cited by 1
Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report
Guimarães, C., Ribeiro, R., Reis, H. H., Ribeiro, M., & Almeida, J. S. (2025) · Cureus · doi:10.7759/cureus.98067 · Cited by 1
Liu, T., Sui, S., An, H., Liu, Q., Gatasheh, M. K., Ahamed, A., & Shao, F. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70623 · Cited by 1
Empagliflozin-induced liver injury
Gonçalves, H. D., Parreira, I., Vasconcelos-Teixeira, S., Melício, A., Dias, M., Lopes, J. M., & Duarte, L. (2025) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2025_005889 · Cited by 1
Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study
Min, T., Tibiletti, M., Hockings, P. D., Galetin, A., Gunwhy, E. R., Shalom, E. S., Kenna, J. G., Melillo, N., Parker, G. J. M., Schuetz, G., et al. (2025) · Radiology · doi:10.1148/radiol.251899 · Cited by 1
Drug-Induced Hepatitis Caused by Methylphenidate: A Case Report
Gonçalves, D. V., Bravo, M., Almeida, S., Ferreira, S., & Rebimbas, S. (2025) · Acta Médica Portuguesa · doi:10.20344/amp.23703 · Cited by 1
Review on clinical diagnosis, pathogenesis and therapeutic strategies of drug-induced liver injury
Tan, X., Gao, J., & Wang, C. (2025) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2025.09.002 · Cited by 1
Tecovirimat hepatotoxicity in a man with Mpox infection
Ruiz-Cabrera, D., Montoya, F. A. D. L. S., Sáez‐Peñataro, J., Riera, J., Vargas, P. M., López‐Suñé, E., López-Pont, M., Martínez-Illán, M., Català, A., Tuset, M., et al. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2026.503030 · Cited by 1
Liu, Y., Ren, H., Bin, Q., Hu, K., Zhu, H., Cheng, Q., Zhang, M., Jiang, C., & Feng, J. (2025) · Journal of Chromatography B · doi:10.1016/j.jchromb.2025.124899 · Cited by 1
Drug-induced hepatotoxicity among critically ill patients in the intensive care unit
Gül, F., & ÜNDER, D. (2025) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.63729/tjic.2025.676 · Cited by 1
Risk factors for drug-induced liver injury in people with HIV on anti-tuberculosis treatment
Martínez-Ayala, P., la Mora, M. S.-D., Velasco, J. A. V.-R., González-Hernández, L. A., Amador-Lara, F., Alanis-Sánchez, G., Aldana-Ledesma, J. M., Alfaro-Rivera, C. G., Zúñiga-Quiñones, S., Ruíz-Herrera, V. V., et al. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2026.503041 · Cited by 1
Suspected Pyridostigmine-Related Hepatotoxicity
DiBenedetto, L. J., Wong, V., Nasir, U., & Asif, B. (2026) · ACG Case Reports Journal · doi:10.14309/crj.0000000000001969 · Cited by 1
Huang, R., Wu, Y., Liu, X., Zou, L., Li, J., He, J., Yang, L., & Yang, X. (2026) · Small · doi:10.1002/smll.202513609 · Cited by 1
Diagnostic value of drug withdrawal observation in drug-induced liver injury: A retrospective study
Liu, Y.-H., Guo, Y., Xu, H., Han, Y., Feng, H., & Pan, F. (2026) · Medicine · doi:10.1097/md.0000000000047340 · Cited by 1
Zhang, D., Du, W., Qin, W., Li, B., li, P., Wang, X., & Chen, W. (2026) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/jcpt/4521997 · Cited by 1
Cai, J., Zhou, G., Jin, F., Xue, H., Li, S., Fu, C., wang, Z., Huang, W., Wang, T., Zhu, F., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340159 · Cited by 1
Analysis of risk factors for herb-induced liver injury: a retrospective study from China
Wang, P., Liang, X., Guangyu, C., Fan, Q., Li, Q., Dai, F., Liu, Y., Jiang, Z., Luo, T., Hu, J., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1766238 · Cited by 1
IIJIMA, N., Ishii, Y., Nakamura, S., Ikemoto, J., Furukawa, M., Yamashita, Y., Nomura, R., Ohtagaki, S., Tanaka, Y., Okada, M., et al. (2026) · Cancers · doi:10.3390/cancers18040685 · Cited by 1
Wei, X., Wei, J., Huang, Y., & Lian, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1727462 · Cited by 1
Huang, W., Hu, Y. H., Li, Z., Che, J., Wang, S., Yang, Y., Yan, S., Chen, Y., Gao, W., Yang, F., et al. (2026) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2026.2633942 · Cited by 1
A Case of Severe Ibrutinib‐Induced Liver Injury and Successful Transition to Acalabrutinib
Ciornolutchii, V., & Ismaiel, A. (2026) · Liver International · doi:10.1111/liv.70573 · Cited by 1
Xue, X., Cui, T., Liu, D., Qiu, H., Wang, H., Yun, Y., Qiu, Y., Yang, W., & Zhang, B. (2026) · Nano Letters · doi:10.1021/acs.nanolett.6c00050 · Cited by 1
Biswas, N., & Dudhia, K. (2026) · Cureus · doi:10.7759/cureus.105372 · Cited by 1
Li, Q., Wang, L., Xu, H., Huang, T., Hong, H., Ji, X., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1753434 · Cited by 1
Alshehri, M. A., Alghamdi, A., Binshaya, A. S., Juraybi, T. N., Abalkhail, A., & Alissa, M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103520 · Cited by 1
Ruiu, A., Calabrese, M. P., Meschisi, P., Plebani, R., Maria, B., Lleò, A., & Ronca, V. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106883 · Cited by 1
Clinical features and management for CDK4/6 inhibitor-DILI
Riveiro‐Barciela, M., Esteban, P. P., Vega-Cano, K. S., Mateos, B., Miranda, E. L., Jara, P., Martín, M. C., López, S. A., Salcedo, M., Forns, X., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101873 · Cited by 1
de Andrade, J. G., de Oliveira, A. R. L., Calumby, B. S. A., Alves, G. G. D. F., de Melo, A. K. G., Braz, A. D. S., & Soares, M. R. M. P. (2026) · Osteoporosis International · doi:10.1007/s00198-026-07988-6 · Cited by 1
Wang, F., Lai, X., Zhou, S., Lin, J. I. N. Y. I., Xin, H., Tao, Z., Wang, X., Zhang, S., LIU, Z., Tan, H., et al. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s598447 · Cited by 1
McIntyre, D., Nguyen, P., 김유진, Meyer, B., & Salloum, M. E. (2026) · Cureus · doi:10.7759/cureus.109764 · Cited by 1
Murcia-Gubianas, C., Vilà-Rivas, M., Ferré, L. T., Bertolin, C., Cernuda, P. S., Espadalé, M. L. P., Sancho, J. M., & Lorencio, C. (2026) · Critical Care · doi:10.1186/s13054-026-06101-x · Cited by 1
Simas, D., Gonçalves, A. R., Gomes, P., Russo, P., Cotrim, I., & Vasconcelos, H. (2026) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000553157 · Cited by 1
Ma, J., Chen, H., Guo, C., He, G., & Yang, G. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2682581 · Cited by 1
Mendoza, E., Pustake, M. V., Annabi, J., Torres, J. A. Q., Mendez, J., Kattamuri, L. P. V., Williams, B., & Deoker, A. (2026) · Case Reports in Gastrointestinal Medicine · doi:10.1155/crgm/1187155 · Cited by 1
Huang, H., Lu, P., Lin, Y.-C., Lin, C., Wang, Y.-L., Chen, T., Chang, K., & Lin, S. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkag221 · Cited by 1
Liu, Y., Hu, K., Geng, J., Dai, Q., Wei, L., & Su, R. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013640 · Cited by 1
Zhu, N., Guo, L., Zhu, J., Xu, W., Wu, J., & Xie, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1827175 · Cited by 1
Li, Y.-K., Zheng, H., Wang, Y., Yang, J., Xu, S., Zhan, P., Zhu, Y., & Du, D. (2026) · International Journal of Medical Robotics and Computer Assisted Surgery · doi:10.1002/rcs.70216 · Cited by 1
Albendazole-Induced Liver Injury Mimicking Autoimmune Hepatitis
Nersisyan, A., Kocharyan, N., Mardanyan, L., Mirumyan, A., & Shahenyan, A. (2026) · Cureus · doi:10.7759/cureus.114878 · Cited by 1
Fu, H., Du, Y., Zhao, G., Xiao, Y., Song, S., Zang, X., Zhou, T., Zhuang, Y., Mo, R., Lai, R., et al. (2026) · Liver International · doi:10.1111/liv.70879 · Cited by 1
Barbaro, L.-E., Ben-Othman, N., Viard, D., Rocher, F., Ewig, E., Mroue, R., Amigues, C., & Gérard, A. O. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70323 · Cited by 1
Atteinte hépatique médicamenteuse
Kumachev, A., & Wu, P. E. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202026-f · Cited by 1
Tuberculosis treatment spills the beans on Wilson’s disease and more
Kumar, V. S., Dhananjaya, S., & Gowda, S. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.08.018 · Cited by 1
Drug-Induced Liver Injury in Older Adults
Miller, E., Abu‐Sbeih, H., & Chalasani, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-90761-1_53-1 · Cited by 1
Vedolizumab-induced cholestatic liver injury
Rojas-Feria, M., Rodríguez-Fernández, M., Castro‐Fernández, M., & García, E. S. (2020) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2020.11.009 · Cited by 1
Updates on current biomarkers in toxicology
Neagu, M. T., Constantin, C., Gaudio, P. D., & García‐González, C. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85215-9.00005-2 · Cited by 1
A medicinal liver injury with an immunomodulatory drug of natural origin. Case report
Reznik, E. V., Yudin, D. V., Gudilova, Y. Y., Baykova, I. E., Karmanova, S. E., & Nikitin, I. G. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.08.200975 · Cited by 1
Su, L., Zhang, J., Jiang, N., Li, J., Yang, J., He, L., Xie, Q., huang, R., Liu, F., Feng, Y., et al. (2021) · Journal of Translational Critical Care Medicine · doi:10.4103/2665-9190.329042 · Cited by 1
Hepatotoxicity Caused By Phenyramidol Hydrochloride: A Case Report
Kara, H., Bayır, A., Güngör, G., & Ak, A. (2021) · Journal of Emergency Medicine Case Reports · doi:10.33706/jemcr.944510 · Cited by 1
Klinisches Management von Patienten mit Leberzirrhose
Bergamin, I., Meyer-Herbon, P., Künzler‐Heule, P., & Semela, D. (2021) · Schweizer Gastroenterologie · doi:10.1007/s43472-021-00058-8 · Cited by 1
Drug-Induced Liver Injury Induced by Bioflavonoids
Pais, J. P., Mota, R., Cruz, M., Cambão, A. R., & Nascimento, A. V. (2021) · Cureus · doi:10.7759/cureus.20453 · Cited by 1
Which NSAID to choose for treatment of pain syndrome in polymorbid patients?
Pereverzev, A. P. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-35-41-46 · Cited by 1
Effects of Omega-3 and Vitamin C on Methotrexate-Induced Liver Injury
Mohammed, D. S., & Al-Gareeb, A. I. A. (2021) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_6_21 · Cited by 1
Menotrophin induced autoimmune hepatitis: a case report
Alqrinawi, S. H., Akbar, N., AlFaddag, H., Akbar, S., Akbar, L., Sohail, A., & Aljawad, M. (2019) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2019.10.00376 · Cited by 1
Herb-Induced Liver Injury: A Report on Two Australian Cases
Peri, V., Yu, C. H. Y., Vaz, K., Asadi, K., & Grace, J. (2022) · Cureus · doi:10.7759/cureus.24686 · Cited by 1
Zaman, N., Parvaiz, N., Farid, R., Navid, A., Abbas, G., & Azam, S. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268454 · Cited by 1
NSAID-Associated Drug-Induced Liver Injury Prior And Following Liver Transplantation
Gümüşsoy, M., Gökcan, H., Bodakçi, E., Kiremitçi, S., Savaş, B., & Idılman, R. (2022) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2021.2021.0050 · Cited by 1
Hepatitis aguda colestásica secundaria a atorvastatina
Martín, C. M., Terrón, P. M. M., & Pajares, F. G. (2022) · Medicina Clínica · doi:10.1016/j.medcli.2022.07.013 · Cited by 1
Elisabeth, M., Budiono, G. V. F., Rahardja, F., & Gunadi, J. W. (2022) · Jurnal Kedokteran Meditek · doi:10.36452/jkdoktmeditek.v28i3.2457 · Cited by 1
Oncological-Therapy-Associated Liver Injuries
Sacerdoțianu, V. M., Streba, C. T., Rogoveanu, I., Streba, L., & Vere, C. C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106214 · Cited by 1
Herb-induced hepatitis secondary to artemisinin: A case report
Zhan, J., Ding, M., Li, J., & Su, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1033906 · Cited by 1
Drug-Induced Liver Injury after IVF: comorbidity, forced polypharmacy
Argunova, I. A. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-203-7-224-238 · Cited by 1
China, L., & Thorburn, D. (2022) · Wiley eBooks · doi:10.1002/9781119802181.ch6 · Cited by 1
A case of autoimmune hepatitis following administration of the COVID19 vaccine
Yagi, S., Tamai, J., Watanabe, T., Yoshida, M., Tokumoto, Y., Abe, M., Murakami, K., Satou, M., Niida, K., Miyamoto, Y., et al. (2022) · Kanzo · doi:10.2957/kanzo.63.491 · Cited by 1
The role of ursodeoxycholic acid in the treatment of hepatobiliary diseases in children
Marushko, Y. V., Dmytryshyn, O. A., Dmytryshyn, B. Y., Bovkun, O. А., & Iovitsa, T. V. (2022) · Modern pediatrics Ukraine · doi:10.15574/sp.2022.125.84 · Cited by 1
Noncirrhotic portal hypertension misdiagnosed as liver cirrhosis: A rare case
Yang, L., Zhen, Z., Li, W., Xiao, L., Chen, L., Xiao, Y., & Wen, Z. (2023) · Portal hypertension & cirrhosis · doi:10.1002/poh2.39 · Cited by 1
75-Year-Old Woman With Deranged Liver Enzymes
Vincent, M. L., Kraft, R. M., & Ratelle, J. T. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.09.021 · Cited by 1
Carrascosa, J. M., Vilarrasa, E., Belinchón, I., Herranz, P., Crespo, J., Guimerá, F., & Olveira, A. (2023) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2023.04.013 · Cited by 1
Wang, X.-X., Huang, A., Gao, S., Hu, W., Wu, J., & Cheng, H. (2023) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/2023/6461165 · Cited by 1
Weltzsch, J. P., Ziegler, A. M., & Lohse, A. W. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01519-9 · Cited by 1
Current Status of Drug-induced Liver Injury in Japan
Tanaka, A. (2022) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.111.1443 · Cited by 1
Oddie, P. D., Heskin, J., Leung, S., Naous, N., Garvey, L. J., & Cohen, C. E. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231185889 · Cited by 1
Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms
Purwar, S., Fatima, A., Bhattacharyya, H., Kutikuppala, L. V. S., Cozma, M.-A., Srichawla, B. S., Komer, L., Nurani, K. M., & Găman, M. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i9.1021 · Cited by 1
Zhang, M.-L., Li, W., Wang, X., Zhang, H., Wu, Y., Yang, L.-Q., Chen, X., Zhang, S., Chen, Y., Feng, K.-R., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259569 · Cited by 1
Kocabey, H., Bekdaş, M., Çetinkaya, A., Düzcü, S. E., Alışık, M., Dinçel, G. K., & Türel, İ. (2023) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v61i11.1326 · Cited by 1
Hanafy, A. S., Embaby, A., Salem, S. M., Behiry, A., Ebrahim, H. A., Elkattawy, H. A., Abed, S. Y., Almadani, M. E., & El‐Sherbiny, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247578 · Cited by 1
Wang, Y., Ma, J., Ma, S., Wang, J., & Li, J. (2023) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc40787.2023.10340721 · Cited by 1
A rare case of alpha-methyldopa-induced hepatitis in pregnancy
Likić-Ladjević, I., Petronijevic, M. A., Vrzić-Petronijević, S., Beleslin, A., & Dugalić, S. (2024) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh231107004l · Cited by 1
Granulomas in Pediatric Liver Biopsies: Single Center Experience
Shaheen, M., Lei, G.-S., Relich, R. F., Jarasvaraparn, C., Tolliver, K. M., Molleston, J. P., & González, I. (2024) · Pediatric and Developmental Pathology · doi:10.1177/10935266231221908 · Cited by 1
Drug-induced liver injury: toxins and antidotes
Cozma, M.-A., Mandea, M., & Diaconu, C. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824472-2.00008-7 · Cited by 1
Hepatitis inmunomediada: conceptos básicos y tratamiento
Velasco, J. A. V.-R., Calderón, D. K. T., Cerpa‐Cruz, S., Chávez, J. A. V., Martínez, J. F. U., García-Jiménez, E. S., Ledesma, J. M. A., Díaz‐González, Á., & Crespo, J. (2024) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2023.12.003 · Cited by 1
Pantoprazole-Induced Liver Injury in the Setting of Diabetic Ketoacidosis
Oliveira, R., de Almeida, M. T. B., Lavado, P., & Baptista, A. (2024) · Acta Médica Portuguesa · doi:10.20344/amp.20928 · Cited by 1
Update zu medikamenteninduzierten Leberschäden
Niederau, C. (2024) · Gastro-News · doi:10.1007/s15036-024-3676-x · Cited by 1
Gürsel, G., Mammadova, A., Aydın, E. M., Çınar, Z., Navruzvai, N., & Cengiz, S. K. (2024) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2024.06.002 · Cited by 1
4-week results of “Linni Slim” synbiotic in patients with metabolic syndrome
Rudoy, A. S., & Silivinchik, N. N. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-223-3-87-96 · Cited by 1
Safe Prescribing in Patients with Kidney and Hepatic Diseases
Tesfaye, W. H., Castelino, R. L., Zolezzi, M., & Small, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-51089-2_22 · Cited by 1
Ferdinande, K., DeClerck, L., Melis, C., Missiaen, L., Seynhaeve, L., Vloo, C. D., & Decaestecker, J. (2024) · Acta gastro-enterologica belgica · doi:10.51821/87.2.12034 · Cited by 1
Gürsel, G., Mammadova, A., Aydın, E. M., Çınar, Z., Navruzvai, N., & Cengiz, S. K. (2024) · Medicina Intensiva · doi:10.1016/j.medin.2024.05.013 · Cited by 1
Zhang, P., Tang, G., Gao, H., Zhang, T.-S., Yang, S., Cheng, T., & Yao, R. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1451133 · Cited by 1
Metadata
- Authors
- Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 70
- Issue
- 6
- Pages
- 1222-1261
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2924328881
- Semantic Scholar
- 6d774d1c570eef200451a1e8a8f5655c367a4eaf
- Cited by
- 1,276
- References
- 371
- Citations by year
- 2026: 243 · 2025: 211 · 2024: 175 · 2023: 159 · 2022: 158 · 2021: 184 · 2020: 117 · 2019: 27
- FWCI
- 78.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Cooperation in Science & Technology
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, idiosyncratic drug-induced liver injury, hepatotoxicity, acute liver failure, risk factors, diagnosis, risk minimization
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Histocompatibility Testing, Humans, Liver Neoplasms, Male, Middle Aged, Mitochondria, Risk Factors, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
